Literature DB >> 1174946

CNS depressants: effects on post-synaptic pharmacology.

J L Barker.   

Abstract

(1) The effects of 5 anesthetics (chloralose, chloroform, ethanol, pentobarbital and urethane) and one anticonvulsant (diphenylhydantoin) were studied on the membrane properties and post-synaptic responses of crustacean neuromuscular junction preparations and molluscan neurons to putative transmitters and peptides. (2) In crustacean preparations pentobarbital selectively depressed, in a dose-dependent, reversible manner, post-synaptic, Na+-dependent, depolarizing responses to the putative transmitter glutamate without altering post-synaptic, Cl(-)-dependent inhibitory responses to the putative transmitter gamma-aminobutyric acid. (3) The effects of all the agents on post-synaptic pharmacology of a molluscan neurosecretory cell were studied either by causing the cell to hyperpolarize to about--100mV through repeated application of acetylcholine (ACh) in a K+-free, Ca++-containing solution or by hyperpolarization through injection of intracellular current in a K+-free solution. Effects of these agents on post-synaptic responses on other molluscan neurons were studied using intracellular current injection to manipulate membrane potential. (4) All of the agents tested selectively depressed the depolarizing Na+-K+-dependent post-synaptic responses of the neurosecretory cell to ACh in a dose-dependent reversible manner without appreciably altering the membrane properties of the cell (over the potential range of the ACh responses). (5) Pentobarbital did not alter the inversion potential of the ACh response. (6) Reciprocal plot analysis of all of the agents tested revealed that the antagonism of the ACh response was primarily non-competitive. (7) None of the agents tested altered hyperpolarizing, K+-dependent responses to dopamine and glutamate on the neurosecretory cell, nor did they affect either the induction or enhancement of BPP activity by the vertebrate peptide vasopressin on this cell.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1174946     DOI: 10.1016/0006-8993(75)90526-0

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  13 in total

1.  Facilitation of synaptic transmission by general anaesthetics.

Authors:  M E Morris
Journal:  J Physiol       Date:  1978-11       Impact factor: 5.182

2.  Effects of several inhalation anaesthetics on the kinetics of postsynaptic conductance changes in mouse diaphragm.

Authors:  P W Gage; O P Hamill
Journal:  Br J Pharmacol       Date:  1976-06       Impact factor: 8.739

3.  Pentobarbital: presynaptic effect in the squid giant synapse.

Authors:  K G Morgan; S H Bryant
Journal:  Experientia       Date:  1977-04-15

4.  Action of enflurane on cholinergic transmission in identified Aplysia neurones.

Authors:  H Arimura; Y Ikemoto
Journal:  Br J Pharmacol       Date:  1986-11       Impact factor: 8.739

5.  Antagonism by some antihistamines of the amino acid-evoked responses recorded from the lobster muscle fibre and the frog spinal cord.

Authors:  A Constanti; A Nistri
Journal:  Br J Pharmacol       Date:  1976-12       Impact factor: 8.739

6.  Drug blockade of open end-plate channels.

Authors:  P R Adams
Journal:  J Physiol       Date:  1976-09       Impact factor: 5.182

7.  The effects of anaesthetics on the uptake and release of amino acid neurotransmitters in thalamic slices.

Authors:  T J Kendall; M C Minchin
Journal:  Br J Pharmacol       Date:  1982-01       Impact factor: 8.739

8.  Postsynaptic actions of ethanol and methanol in crayfish neuromuscular junctions.

Authors:  W Finger; H Stettmeier
Journal:  Pflugers Arch       Date:  1984-02       Impact factor: 3.657

9.  Pentobarbitone pharmacology of mammalian central neurones grown in tissue culture.

Authors:  J L Barker; B R Ransom
Journal:  J Physiol       Date:  1978-07       Impact factor: 5.182

10.  General anaesthetics and the acetylcholine-sensitivity of cortical neurons.

Authors:  J C Smaje
Journal:  Br J Pharmacol       Date:  1976-11       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.